Moderna, Inc.
(NASDAQ: MRNA)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

25.484

-0.416 (-1.61%)
Range 25.160 - 25.965   (3.20%)
Open 25.550
Previous Close 25.900
Bid Price 138.850
Bid Volume 8
Ask Price 139.500
Ask Volume 11
Volume 3,948,253
Value -
Remark
Delayed prices. Updated at 24 Jun 2025 02:06.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis